Search

everythinglearnresearchcommunity

for

Search:↓

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Suppressing certain hormones might help prevent prostate cancer.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

HPV8 causes skin cancer by expanding specific skin stem cells.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Consider benefits and risks of new alopecia treatments for safety.

The document suggests a possible link between FAM111B gene mutations and increased cancer risk, particularly pancreatic cancer.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Men with baldness are more prone to skin cancers on the scalp due to sun exposure, not testosterone.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

A specific hair diffraction pattern may indicate breast cancer if tested with the correct method.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Certain microRNAs found in normal cells can effectively suppress various cancers.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.